Major changes are in store for sponsors of quinolone and fluoroquinolone antibiotics in the EU. The European Medicines Agency has issued recommendations to remove some of these medicines from the market and to change the labeling of others to severely restrict their use in patients due to concerns of potentially long-lasting side effects.
EMA Acts On Patient Concerns Over Fluoroquinolone Antibiotics
Three months after hearing testimonies of patients who suffered severe side-effects from the use of quinolones and fluoroquinolones, the European Medicines Agency has recommended that some of these medicines should be removed from the market and the labeling of others should be changed to restrict their use.
